| 800568 |
EXPERIMENTAL AND THERAPEUTIC MEDICINE |
Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma |
2022-02-01 |
10.3892/etm.2022.11177 |
Lu Fenying, Chen Weichang, Jiang Tingwang, Cheng Cuie, Wang Bin, Lu Zhiping, Huang Guojin, Qiu Jiaming, Wei Wei, Yang Ming, Huang Xia |
| 800567 |
EXPERIMENTAL AND THERAPEUTIC MEDICINE |
Correlations between periodontal indices and osteoporosis |
2022-02-01 |
10.3892/etm.2022.11179 |
Preda Smaranda, Comanescu Maria, Albulescu Dana, Dascălu Ionela, Camen Adrian, Cumpătă Cristian, Perlea Paula, Bugălă Narcis, Stoica Elena, Gheorghiță Lelia, Diaconu Oana, Tuculina Mihaela |
| 800566 |
ACTA ASTRONAUTICA |
On perturbation solutions in the restricted three-body problem dynamics |
2022-02-01 |
10.1016/j.actaastro.2022.01.022 |
Lara Martin |
| 800565 |
ACTA ASTRONAUTICA |
IFC - Publication Information |
2022-02-01 |
10.1016/s0094-5765(21)00674-3 |
|
| 800564 |
ACTA ASTRONAUTICA |
Experimental study on the spray characteristics of a pintle injector element |
2022-02-01 |
10.1016/j.actaastro.2022.02.019 |
Zhou Rui, Shen Chibing |
| 800563 |
ACTA ASTRONAUTICA |
Spectral mass gauging in terrestrial gravity and microgravity conditions |
2022-02-01 |
10.1016/j.actaastro.2022.01.032 |
Fili Thomas, Quintana-Buil Guillem, González-Cinca Ricard |
| 800562 |
ACTA ASTRONAUTICA |
B-plane and Picard-Chebyshev integration method: Surfing complex orbital perturbations in interplanetary multi-flyby trajectories |
2022-02-01 |
10.1016/j.actaastro.2022.01.045 |
Masat Alessandro, Colombo Camilla |
| 800561 |
CLINICAL GENITOURINARY CANCER |
Table of contents |
2022-02-01 |
10.1016/s1558-7673(22)00014-3 |
|
| 800560 |
CLINICAL GENITOURINARY CANCER |
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men with Metastatic Castration-Resistant Prostate Cancer |
2022-02-01 |
10.1016/j.clgc.2022.02.002 |
Anand Aseem, Heller Glenn, Fox Joseph, Danila Daniel C., Bjartell Anders, Edenbrandt Lars, Larson Steven M., Scher Howard I., Morris Michael J. |
| 800559 |
CLINICAL GENITOURINARY CANCER |
Coordinated pembrolizumab and high dose IL-2 (5-in-a-row schedule) for therapy of metastatic clear cell renal cancer |
2022-02-01 |
10.1016/j.clgc.2022.01.010 |
Chatzkel Jonathan, Schell Michael J., Chahoud Jad, Jain Rohit, Zhang Jingsong, Swank Jennifer, Ludlow Steve, Lombardi Kristina, Lucas Yesenia, Croft Cortlin, Rembisz Jennifer, Jameel Gigi, Fishman Mayer |
